Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-10-06 MARCHIO ALBERT N II Chief Acct. & Op., Asst. Sec. Conversion +5,504 5,504
2015-10-06 MARCHIO ALBERT N II Chief Acct. & Op., Asst. Sec. Purchase +100 $11.00 $1K 6,504
2015-10-06 MARCHIO ALBERT N II Chief Acct. & Op., Asst. Sec. Other acquisition +357 $7.24 $3K 6,861
2015-10-06 MARCHIO ALBERT N II Chief Acct. & Op., Asst. Sec. Conversion · Series C-1 Convertible Preferred Stock −7,530 0
2015-10-06 Vaish Renu V.P., Global Reg. Affairs Purchase +350 $11.00 $4K 350
2015-10-06 Faleck Herbert J Chief Medical Officer Purchase +500 $11.00 $6K 500

Page 18 of 18 · 346 trades